Here is how Ardelyx (ARDX) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
Related Posts
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals an…
3 Marijuana Stocks For 2026 Investing
Finding top marijuana stocks to buy in 2026 may be easier than some believe.
Is Now the Time to Buy One of the Worst-Performing “Magnificent Seven” Stocks of 2025?
Up until last week, Amazon was the worst performer of the bunch so far in 2025.